Firefly Bio

Firefly Bio is a biotechnology company specializing in the development of innovative gene therapies aimed at treating rare genetic disorders. They generate revenue through the research, development, and commercialization of these therapies, often partnering with pharmaceutical companies and research institutions. Founded in 2015, Firefly Bio has made significant strides in gene editing technologies, particularly with their proprietary CRISPR-based platforms, positioning themselves as leaders in the biotech industry. Their mission is to transform the lives of patients with previously untreatable conditions, driving advancements in personalized medicine.

Recent Posts by Firefly Bio

1-4 of 4